Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Ravenquest Biomed Inc RVVQF

Ravenquest BioMed Inc is a Canada-based diversified cannabis company with divisions focused upon cannabis production, management services and consulting and specialized research and development. It provides integrated solutions to companies in the cannabis industry and provides growing and drying technologies, patient and genetic management systems, and security management solutions The company operates through the following segments - Consulting business and Cultivation and Sale of Medical Cannabis.


GREY:RVVQF - Post by User

Comment by cornwallison Oct 11, 2019 5:50pm
136 Views
Post# 30224029

RE:Next Catalyst

RE:Next Catalyst
Since RQB already has a cultivation license for Edmonton, would the licensing of the additional rooms be considered a license amendment instead of a new license? Does that Health Canada table typically list license amendments in some way?
 
Take the "Verdlite Sciences, Inc." entry in that table, for example. There was this press release a few days ago. It's about how that facility "has received from Health Canada a license amendment for the complete growing and processing area in its 88,000 square foot indoor facility. The additional 50,000 square feet will allow Verdlite to expand production from 4 to 21 highly-controlled-environment grow rooms and to a total of 16 processing rooms."

To me, that sounds similar to the RQB situation. However, I don't see anything in that Health Canada table indicating that amendment for Verdlite. That makes me wonder if we'd actually see any change for the Alberta Green Biotech Inc. entry once the rest of the rooms are licensed. Maybe we'd have to wait for a press release from RQB?
<< Previous
Bullboard Posts
Next >>